Does lower DHEA sulfate reduce the adrenal precursor pool and contribute to low free testosterone in postmenopausal women?

Following the menopausal transition, ovarian steroid production declines precipitously, shifting the responsibility for androgen synthesis largely to the adrenal glands. DHEA sulfate (DHEA-S) serves as the primary systemic reservoir for downstream sex steroids in postmenopausal women.

Precursor depletion and intracrine signaling

• Adrenal reservoir depletion: DHEA-S is converted from DHEA via the sulfotransferase SULT2A1 to form a highly stable, circulating precursor pool. Natural, age-related declines in DHEA-S deplete this reservoir, limiting the substrate available for peripheral tissues.
• Intracrine conversion: Because peripheral target tissues rely on the local desulfation of circulating DHEA-S to facilitate downstream signaling, a depleted precursor pool directly limits local, tissue-specific androgen conversion.

Impact on free testosterone and SHBG dynamics

• Androgen synthesis: In the absence of robust ovarian activity, peripheral conversion of adrenal DHEA-S is the principal pathway for producing testosterone. Consequently, a depleted precursor pool restricts overall testosterone synthesis, contributing to lower circulating free testosterone.
• Hormonal modulators: While systemic free testosterone levels are heavily modulated by sex hormone-binding globulin (SHBG) dynamics—wherein postmenopausal estrogen decline reduces SHBG, increasing the fraction of unbound, free testosterone—precursor availability remains a critical baseline constraint.
• Clinical response: Low DHEA-S levels frequently co-occur with low free testosterone in women presenting with androgenic deficiency. Clinical studies demonstrate that DHEA supplementation significantly elevates circulating DHEA-S and downstream free testosterone, validating the dependency of free hormone levels on the adrenal precursor pool.

Bottom line

• Adrenal-derived DHEA-S is the vital substrate reservoir for peripheral androgen synthesis in postmenopausal women; its depletion directly limits local intracrine conversion, contributing to low free testosterone and diminished androgenic activity.